Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 60 #1
CompanyImmunoGen, Inc.
Market Cap525.09MEPS (ttm)-0.96
P/E-EPS this Y4.60%
Forward P/E-EPS next Y-6.00%
PEG-EPS past 5Y-5.70%
P/S9.39EPS next 5Y-
P/B8.86EPS Q/Q-100.00%
Dividend-Sales Q/Q-23.30%
Insider Own0.20%Inst Own91.20%
Insider Trans7.51%Inst Trans2.32%
Short Float10.23%EarningsOct 24/b
Analyst Recom2.70Target Price12.41
Avg Volume1.29M52W Range7.70 - 17.80
Dec-19-14 03:11PMImmunoGen's stock plunges after Roche's disappointing trial results prompts downgrade at MarketWatch
Dec-19-14 01:33PMMid-Day Losers From December 19: ImmunoGen, NQ Mobile And More Benzinga
Dec-19-14 12:47PMJuno Therapeutics IPO Caps Big Year In Biotech Deals at Investor's Business Daily
Dec-19-14 11:31AMRoche Drugs For Alzheimer's, Breast Cancer Disappoint at Investor's Business Daily
Dec-19-14 10:46AMCramer: Downside to Biotech as ImmunoGen Stock Cut in Half at TheStreet
Dec-19-14 10:35AMImmunoGen (IMGN) Stock Plummets to One-Year Low on Disappointing Breast Cancer Drug Results at TheStreet
Dec-19-14 09:24AMCramer's Mad Dash: Tale of two biotechs CNBC
Dec-19-14 08:14AMAhead of the Bell: ImmunoGen shares tumble AP
Dec-19-14 01:02AMImmunoGen Reports Roche Has Provided an Update on the MARIANNE Trial Business Wire
ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. The company offers Kadcyla, an antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer. Its product candidates include IMGN853, which is in Phase I clinical trials for the treatment of ovarian cancer, endometrial cancer, and other cancers; IMGN289 that is in Phase I clinical trials for treating squamous cell carcinoma of head and neck cancer, and non-small cell lung cancer; IMGN529, which is in Phase I clinical trials for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia; and IMGN779 that is in preclinical stage for treating acute myeloid leukemia. The company also develops compounds, such as AMG 172 that is in Phase I clinical trials for the treatment of clear cell renal cell carcinoma; AMG 595, which is in Phase I clinical trials for treating glioblastoma; BAY 94-9343 is in early clinical trials for the treatment of mesothelioma and ovarian cancer; BT-062 for multiple myeloma; SAR3419, which has completed Phase II clinical trials for the treatment of diffuse large B-cell lymphoma; SAR650984 that is in early clinical trials for the treatment of multiple myeloma; SAR566658 that is in Phase I clinical trials for treating CA6-positive solid tumors; and SAR408701 for solid tumors. It has collaborations with Amgen Inc.; Bayer HealthCare; Biotest AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; the Roche Group; and Sanofi. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morris Charles QExecutive VP & CDONov 28Sale10.405,24054,49632,260Dec 02 10:25 AM
JUNIUS DANIEL MChief Executive OfficerSep 19Option Exercise5.7417,42199,99798,057Sep 22 01:14 PM
BARROWS CRAIGVice-President,General CounselMay 05Option Exercise3.3015,00049,50021,100May 05 04:45 PM
JUNIUS DANIEL MChief Executive OfficerMar 17Option Exercise5.7415,00086,10095,636Mar 18 09:41 AM
JUNIUS DANIEL MChief Executive OfficerMar 17Sale16.4015,000246,00080,636Mar 18 09:41 AM
TickerGSS [AMEX]
CompanyGolden Star Resources, Ltd.
Market Cap272.30MEPS (ttm)-0.67
P/E-EPS this Y-12.50%
Forward P/E-EPS next Y33.30%
PEG-EPS past 5Y-28.90%
P/S0.80EPS next 5Y10.00%
P/B0.84EPS Q/Q0.00%
Dividend-Sales Q/Q-34.20%
Insider Own0.23%Inst Own61.40%
Insider Trans-0.51%Inst Trans-0.42%
Short Float1.10%EarningsFeb 23/a
Analyst Recom3.40Target Price0.36
Avg Volume1.40M52W Range0.19 - 0.89
Dec-18-14 04:16PMGolden Star Resources Announces Filing of PEA for Prestea Mine CNW Group
Dec-18-14 04:16PMGolden Star Resources Announces Filing of PEA for Prestea Mine PR Newswire
Dec-04-14 04:01PMGolden Star Operations to Support Load Shedding Plan in Ghana Marketwired
Nov-20-14 05:46AMGolden Star Resources (GSS) Crumbles: Stock Tumbles by 8.8% Zacks
Nov-19-14 01:54AMGolden Star Resources (GSS) in Focus: Stock Moves Up 7.4% Zacks
Nov-13-14 07:00AMGolden Star's Prestea Mine PEA Indicates NPV of $121 M for Initial Capital Expenditure of $40 M Marketwired
Nov-10-14 12:16PMGolden Star to Host Investor Conference Call Marketwired
Nov-05-14 05:08PMGolden Star Announces Appointment of Daniel Owiredu to Board of Directors Marketwired
Nov-05-14 04:58PMGolden Star Third Quarter 2014 Financial Results Marketwired
Nov-03-14 08:35AMGold Stocks Technical Analysis - New Gold, Randgold Resources, Golden Star Resources, Cia de Minas Buenaventura, and Agnico Eagle Mines PR Newswire
Golden Star Resources Ltd. operates as a gold mining and exploration company. It owns and operates the Wassa open-pit gold mine, the Father Brown open-pit gold mine, and a carbon-in-leach processing plant located approximately 35 kilometers from the town of Bogoso; and the Bogoso gold mining and processing operation located near the town of Bogoso in Ghana. The company also has a 90% interest in the Prestea Underground mine in Ghana. In addition, it holds interests in various gold exploration projects in Ghana and other parts of West Africa, and in South America, as well as holds and manages exploration properties in Brazil. The company was founded in 1984 and is headquartered in Toronto, Canada.
TickerGMO [AMEX]
CompanyGeneral Moly, Inc.
IndustryIndustrial Metals & Minerals
Market Cap26.24MEPS (ttm)-0.11
P/E-EPS this Y-63.60%
Forward P/E-EPS next Y-8.30%
PEG-EPS past 5Y3.00%
P/S-EPS next 5Y0.00%
P/B0.20EPS Q/Q-233.30%
Dividend-Sales Q/Q-
Insider Own2.40%Inst Own18.40%
Insider Trans8.62%Inst Trans-13.36%
Short Float3.47%EarningsAug 04
Analyst Recom3.00Target Price1.33
Avg Volume190.82K52W Range0.30 - 1.54
Nov-14-14 01:04PMGENERAL MOLY, INC Financials EDGAR Online Financials
Nov-03-14 09:31AMGENERAL MOLY, INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-03-14 08:00AMGeneral Moly Announces Third Quarter 2014 Results Business Wire
Oct-30-14 05:00PMGeneral Moly to Attend the Cowen and Company Global Metals, Mining and Materials Conference Business Wire
Sep-24-14 05:00PMGeneral Moly Announces Corporate Update Business Wire
Aug-06-14 08:00AMGeneral Moly to Participate in the Jefferies Global Industrials Conference and the Bank of America Merrill Lynch Canada Mining Conference Business Wire
Aug-04-14 09:30AMGENERAL MOLY, INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-04-14 08:00AMGeneral Moly Announces Second Quarter 2014 Results Business Wire
Jul-30-14 05:30PMGeneral Moly Announces Filing of Updated NI 43-101 Technical Report for the Liberty Project Business Wire
Jul-25-14 08:00AMGeneral Moly Announces U.S. District Court Order Confirming Bureau of Land Management's Record of Decision Approving the Mt. Hope Project Business Wire
General Moly, Inc., a development stage company, explores for, develops, and mines molybdenum properties primarily in the United States. The company also explores for gold, copper, and zinc. It primarily holds 80% interest in the Mt. Hope project that contains proven and probable molybdenum reserves totaling 1.4 billion pounds, located in Eureka County, Nevada; and the Liberty project in Nye County, Nevada. The company was formerly known as Idaho General Mines, Inc. and changed its name to General Moly, Inc. in October 2007. General Moly, Inc. was incorporated in 1925 and is headquartered in Lakewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chaput DavidChief Financial OfficerDec 15Option Exercise0.007,3340138,961Dec 15 12:27 PM
HANSEN BRUCE DChief Executive OfficerDec 15Option Exercise0.0016,66701,373,524Dec 15 12:26 PM
Pennington Robert IraVP Engineering & ConstructionDec 15Option Exercise0.007,3340387,461Dec 15 12:28 PM
Roswell R ScottCorporate Counsel, VP HRDec 15Option Exercise0.004,6670127,441Dec 15 12:29 PM
Shumway LeeController & TreasurerDec 15Option Exercise0.004,6670138,280Dec 15 12:30 PM
CompanyFirst Bank
IndustryRegional - Mid-Atlantic Banks
Market Cap56.18MEPS (ttm)0.65
P/E9.18EPS this Y112.10%
Forward P/E10.85EPS next Y-21.40%
PEG-EPS past 5Y0.00%
P/S3.10EPS next 5Y-
P/B0.88EPS Q/Q121.30%
Dividend-Sales Q/Q71.80%
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float0.07%Earnings-
Analyst Recom1.00Target Price7.75
Avg Volume8.96K52W Range5.85 - 6.96
Dec-18-14 06:00PMNigeria Banks More Exposed Than Russia's to Oil Slump at Bloomberg
Oct-28-14 06:37PMFirst Bank Reports Third Quarter 2014 Earnings of $1.1 Million; Total Assets Reach $643 Million Marketwired
Oct-23-14 03:14PMFirst Bank Recognized as a Top Small-Cap Bank in U.S. Marketwired
Sep-04-14 07:01PMBarclays taps vein biometrics in bank fraud fight Reuters
Jul-29-14 11:06AMFirst Bank Reports Second Quarter 2014 Earnings of $923,000; Total Assets Reach $611 Million Marketwired
Jun-24-14 07:06AMLCNB Corp. (LCNB) Crumbles: Stock Falls 6.1% in Session Zacks
May-15-14 06:09PMFirst Bank reports Q1 EPS 37c, one estimate 28c at
May-15-14 06:06PMFirst Bank Reports First Quarter 2014 Earnings of $3.2 Million; Total Assets Reach $599 Million Marketwired
Mar-29-14 01:04PMFIRST BANKS, INC Financials EDGAR Online Financials
Mar-19-14 07:19AMFirst Bank (FRBA) Jumps: Stock Rises 9.2% Zacks
First Bank provides various banking products and services to individuals, businesses, and governmental entities in New Jersey, the United States. The company offers commercial and industrial loans; commercial real estate loans, including construction and land development, and multi-family loans; residential real estate loans, such as residential mortgages, first lien home equity loans, second lien home equity loans, and home equity revolving lines of credit; and consumer loans consisting of auto loans, personal loans, traditional installment loans, and other loans. It also provides non-interest bearing demand deposits, interest bearing demand accounts, money market accounts, savings accounts, and certificates of deposit, as well as commercial checking accounts. In addition, the company offers electronic banking services, including Internet banking, electronic bill payment, and phone banking; and ATM cards, wire transfers, and automatic and ACH transfers. Further, the company is engaged in investment activities. It operates through eight full-service branches. First Bank was founded in 2006 and is headquartered in Hamilton, New Jersey.
CompanyNeothetics, Inc.
Market Cap89.48MEPS (ttm)-3.26
P/E-EPS this Y-87.20%
Forward P/E-EPS next Y-148.40%
PEG-EPS past 5Y0.00%
P/S-EPS next 5Y-
P/B-EPS Q/Q62.60%
Dividend-Sales Q/Q-
Insider Own13.10%Inst Own40.20%
Insider Trans-Inst Trans-
Short Float0.00%Earnings-
Analyst Recom2.00Target Price18.50
Avg Volume230.95K52W Range6.93 - 14.10
Dec-15-14 09:05AMCoverage initiated on NeoThetics, Inc. by Needham
Dec-01-14 08:11AMNeothetics Announces Closing Of Upsized IPO Benzinga
Dec-01-14 08:00AMNeothetics Announces Closing of Upsized Initial Public Offering GlobeNewswire
Nov-19-14 07:35PMNeothetics Prices Initial Public Offering GlobeNewswire
Neothetics, Inc., a clinical-stage specialty pharmaceutical company, engages in developing therapeutics for the aesthetic market. Its lead product candidate includes LIPO-202, an injectable formulation of salmeterol xinafoate that has completed Phase II development for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients. The company is also developing LIPO-102 for the treatment of the orphan indication of symptomatic exophthalmos, or protrusion of the eye from the orbit, associated with thyroid-related eye disease caused by the expansion of fat and muscle behind the eye. The company was formerly known as Lipothera, Inc. and changed its name to Neothetics, Inc. in August 2014. Neothetics, Inc. was founded in 2007 and is headquartered in San Diego, California.
CompanyFreshpet, Inc.
IndustryFood - Major Diversified
Market Cap502.23MEPS (ttm)-1.22
P/E-EPS this Y-13.10%
Forward P/E161.40EPS next Y118.40%
PEG-EPS past 5Y0.00%
P/S6.36EPS next 5Y-
P/B-EPS Q/Q-60.90%
Dividend-Sales Q/Q52.00%
Insider Own21.30%Inst Own70.60%
Insider Trans-3.68%Inst Trans-27.96%
Short Float7.03%EarningsDec 09/a
Analyst Recom1.70Target Price21.33
Avg Volume968.97K52W Range15.80 - 20.45
Dec-10-14 05:17PMFRESHPET, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Dec-09-14 05:00PMFreshpet Co Earnings Call scheduled for 5:00 pm ET today CCBN
Dec-09-14 04:21PMFRESHPET, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
Dec-09-14 04:05PMFreshpet, Inc. Reports Third Quarter Fiscal 2014 Financial Results GlobeNewswire
Dec-09-14 07:07AMQ3 2014 Freshpet, Inc. Earnings Release - After Market Close CCBN
Dec-02-14 06:54AMCoverage initiated on Freshpet by Stifel, Robert W. Baird and Canaccord Genuity
Nov-24-14 04:05PMThe 52-Week Low Club for Monday at 24/7 Wall St.
Nov-24-14 08:00AMFreshpet, Inc. to Report Third Quarter 2014 Results on Tuesday, December 9, 2014 GlobeNewswire
Nov-19-14 02:18PMFRESHPET, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligat EDGAR Online
Nov-13-14 11:12AMFreshpet, Inc. Closes Its Initial Public Offering GlobeNewswire
Freshpet, Inc. manufactures and markets natural fresh foods, refrigerated meals, and treats for dogs and cats in the United States and Canada. The company sells its products under the Freshpet, Dognation, and Dog Joy brand names. Freshpet, Inc. distributes its products through grocery, mass, club, pet specialty, and natural retail classes. The company was incorporated in 2004 and is headquartered in Secaucus, New Jersey.
CompanyTecogen Inc.
IndustryDiversified Machinery
Market Cap72.61MEPS (ttm)-0.25
P/E-EPS this Y-116.70%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.82EPS next 5Y-
P/B11.77EPS Q/Q18.20%
Dividend-Sales Q/Q44.80%
Insider Own56.04%Inst Own9.40%
Insider Trans0.10%Inst Trans85.87%
Short Float1.79%Earnings-
Analyst Recom-Target Price-
Avg Volume14.48K52W Range4.95 - 31.31
Dec-18-14 10:20AMTecogen Sells Natural Gas Driven Cogeneration Unit to New Luxury Condominium Residence in Hudson Yards, New York PR Newswire
Dec-16-14 10:20AMTecogen Sells Two Ultra InVerde Combined Heat and Power (CHP) Systems to Brooklyn-based Award Winning Nursing and Rehabilitation Center PR Newswire
Dec-11-14 10:20AMTecogen Sells Two InVerdeĀ® INV-100 Combined Heat and Power (CHP) Systems to AmericanDG Energy's subsidiary, EuroSite Power PR Newswire
Dec-10-14 09:40AMControlling Demand Response Instrumental in Lower Electric Bills and Higher Profits Accesswire
Dec-09-14 09:30AMTecogen Sells Cogeneration System to Massachusetts-based Department of Defense Laboratory PR Newswire
Dec-04-14 09:45AMTecogen Sells Cogeneration System to Another Prestigious Condominium Residence in Manhattan PR Newswire
Dec-02-14 09:45AMTecogen Announces Sales of Tecochill Natural Gas Powered Chillers to Two Major East Coast Manufacturing Facilities PR Newswire
Nov-25-14 09:30AMTecogen Sells Efficient Gas Chiller to Highly Regarded Upper West Side New York City Nursing Home PR Newswire
Nov-24-14 09:45AMMicrogrids and On-Site Power Offer Relief to an Aging Electricity Grid Accesswire
Nov-21-14 01:04PMTECOGEN INC. Financials EDGAR Online Financials
Tecogen Inc. designs, manufactures, sells, and services systems that produce electricity, hot water, and air conditioning for commercial installations and buildings, and industrial processes. The company offers cogeneration units that supply electricity and hot water; chillers that provide air-conditioning and hot water; and high-efficiency water heaters. Its products include InVerde, a 100-kilowatt combined heat and power system that primarily provides electricity and hot water; TECOGEN cogeneration system, which produces approximately 500,000 Btu/hr of hot water; TECOCHILL natural gas engine-driven chillers; and Ilios high-efficiency water heaters. The company also provides long-term maintenance contracts, parts sales, and installation services. Tecogen Inc. offers its products and services for hospitals and nursing homes, colleges and universities, health clubs and spas, hotels and motels, office and retail buildings, food and beverage processors, multi-unit residential buildings, laundries, ice rinks, swimming pools, factories, municipal buildings, and military installations. The company is headquartered in Waltham, Massachusetts.
CompanyEuro Tech Holdings Company Limited
CountryHong Kong
IndustryPollution & Treatment Controls
Market Cap6.00MEPS (ttm)-0.01
P/E-EPS this Y95.20%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-16.50%
P/S0.32EPS next 5Y-
P/B0.38EPS Q/Q-75.00%
Dividend-Sales Q/Q-14.00%
Insider Own51.22%Inst Own2.30%
Insider Trans-Inst Trans14.42%
Short Float0.00%EarningsApr 22
Analyst Recom-Target Price-
Avg Volume3.64K52W Range3.04 - 6.75
Dec-12-14 06:00AMEuro Tech Holdings Company Limited Reports Stock Option Granted PR Newswire
Jul-24-14 01:04PMEURO TECH HOLDINGS CO LTD Financials EDGAR Online Financials
Jul-21-14 01:15PMWhy Euro Tech Holdings (CLWT) Stock Is Soaring Today at TheStreet
Jul-21-14 08:00AMEuro Tech Holdings Company Limited Reports Ballast Water Treatment Systems ("BWTS") Update PR Newswire
Jun-24-14 12:11PMEuro Tech Holdings falls over 12% after CCS may take more time for review
Jun-24-14 08:00AMEuro Tech Holdings Company Limited Reports Ballast Water Treatment Systems ("BWTS") Update PR Newswire
Apr-29-14 06:00PMEuro Tech Holdings Company Limited Reports 2013 Year-End Results PR Newswire
Dec-27-13 07:00AMEuro Tech Holdings Company Limited Reports Interim Results For The Six Months Ended June 30, 2013 PR Newswire
Dec-20-13 09:25AM2013 Christmas Stock Pick - Euro Tech Holdings Is In The Right Place At The Right Time at Seeking Alpha
Euro Tech Holdings Company Limited distributes advanced water treatment equipment for commercial customers and governmental agencies, or instrumentalities in Hong Kong and the People's Republic of China. It operates in two segments, Trading and Manufacturing, and Engineering. The company offers analytical instruments, such as chromatographs, mass spectrometers, flow injector analyzers, automated sample preparation workstations, and atomic spectrometers; environmental monitoring instruments comprising air and water quality monitoring instruments; sample pre-treatment equipment; and general purpose laboratory instruments consisting of water quality monitoring and analysis equipment. It also provides general testing and measuring equipment comprising multi-channel digital and analogue recorders, signal amplifiers, and calibration equipment for energy conservation, renewable energy equipment, power quality analyzers, continuous emissions monitoring systems, and air pollution control systems to power plants, railway and aero-space industries, utilities, educational institutions, and telecommunications companies. In addition, the company offers process control and engineering products, including sensors, temperature gauges, pressure gauges, power and energy consumption meters, flow meters, valves, temperature and pressure transmitters and control devices, and temperature and pressure calibrators, as well as moisture, power, energy, and harmonic analyzers. Further, it is involved in the development, production, sale, and servicing of environmental equipment, including laboratory analyzers, on-line measuring equipment, and other analyzers for chemicals; and provision of maintenance, installation assistance, and calibration services. The company distributes its products through its trading companies and representative offices. Euro Tech Holdings Company Limited was founded in 1971 and is headquartered in Hong Kong, Hong Kong.
TickerLEU [NYSE]
CompanyCentrus Energy Corp.
IndustryIndustrial Metals & Minerals
Market Cap37.49MEPS (ttm)259.45
P/E0.02EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-44.50%
P/S0.05EPS next 5Y-
P/B0.03EPS Q/Q709.70%
Dividend-Sales Q/Q-60.30%
Insider Own0.10%Inst Own-
Insider Trans-94.98%Inst Trans-
Short Float0.73%Earnings-
Analyst Recom-Target Price-
Avg Volume127.16K52W Range4.20 - 135.72
Dec-10-14 04:27PMCENTRUS ENERGY CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Nov-21-14 01:04PMCENTRUS ENERGY CORP Financials EDGAR Online Financials
Nov-16-14 07:08PM10-Q for USEC, Inc. Company Spotlight
Nov-14-14 09:00AMCentrus Energy Corp Earnings Call scheduled for 9:00 am ET today CCBN
Nov-14-14 07:23AMCENTRUS ENERGY CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
Nov-14-14 07:00AMCentrus Reports Third Quarter 2014 Results Business Wire
Nov-11-14 06:00AM5 Under-$10 Stocks Ready to Trade Higher: Penn Virginia and More at TheStreet
Nov-10-14 06:14PMCentrus to Webcast Conference Call on November 14 at 9 a.m. ET Business Wire
Nov-03-14 07:19AMCentrus Energy Corp. Regains Compliance with NYSE Listing Standards Business Wire
Oct-31-14 04:08PMCENTRUS ENERGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Centrus Energy Corp. supplies low enriched uranium (LEU) for commercial nuclear power plants in the United States, Japan, and internationally. The company operates in two segments, LEU and Contract Services. Its LEU is a component in the production of nuclear fuel for reactors to produce electricity. The company sells separative work units (SWU) component of LEU; SWU and uranium components of LEU; and uranium for utilities that operate nuclear power plants. It also provides contract work services for the U.S. Department of Energy and its contractors. The company was formerly known as USEC Inc. and changed its name to Centrus Energy Corp. in September 2014. Centrus Energy Corp. was founded in 1951 and is headquartered in Bethesda, Maryland.
CompanyIconix Brand Group, Inc.
IndustryTextile - Apparel Footwear & Accessories
Market Cap1.60BEPS (ttm)2.65
P/E12.57EPS this Y38.80%
Forward P/E11.04EPS next Y9.75%
PEG0.84EPS past 5Y15.40%
P/S3.52EPS next 5Y15.00%
P/B1.74EPS Q/Q16.00%
Dividend-Sales Q/Q6.20%
Insider Own4.70%Inst Own-
Insider Trans-0.84%Inst Trans2.25%
Short Float27.16%EarningsOct 28/b
Analyst Recom2.60Target Price45.64
Avg Volume774.00K52W Range35.20 - 44.81
Nov-19-14 12:02PMTrade-Ideas: Iconix Brand Group (ICON) Is Today's "Barbarian At The Gate" Stock at TheStreet
Nov-14-14 01:04PMICONIX BRAND GROUP, INC. Financials EDGAR Online Financials
Nov-14-14 06:12AMWhy Iconix Brand Group (ICON) Could Be an Impressive Growth Stock Zacks
Nov-13-14 12:29PMIconix Brand Group To Present At The Morgan Stanley Global Consumer & Retail Conference PR Newswire
Nov-11-14 05:47AMCoverage initiated on Iconix Brand by ROTH Capital
Nov-09-14 07:09PM10-Q for Iconix Brand Group, Inc. Company Spotlight
Nov-07-14 04:37PMICONIX BRAND GROUP, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-04-14 04:56PMICONIX BRAND GROUP, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Oct-30-14 08:00AMIconix Brand Group Announces Appointment Of Sue Gove To Its Board Of Directors PR Newswire
Oct-29-14 04:29PMICONIX BRAND GROUP, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Submission of Matters to EDGAR Online
Iconix Brand Group, Inc., a brand management company, is engaged in licensing, marketing, and providing trend direction for a portfolio of consumer and entertainment brands primarily in the United States and internationally. The company owns and licenses Candie's, Bongo, Badgley Mischka, Joe Boxer, Rampage, Mudd, Mossimo, London Fog, Ocean Pacific, Danskin, Rocawear, Cannon, Royal Velvet, Fieldcrest, Charisma, Starter, Waverly, Zoo York, Ed Hardy, Sharper Image, Umbro, Lee Cooper, Ecko Unltd, and Marc Ecko brand names. It also owns interests in the Artful Dodger, Material Girl, Peanuts, Truth or Dare, Billionaire Boys Club, Ice Cream, Modern Amusement, and Buffalo brands. Iconix Brand Group, Inc. licenses its brands directly to retailers, wholesalers, and suppliers for use across a range of product categories, including apparel, footwear, sportswear, fashion accessories, home products and decor, beauty and fragrance, consumer electronics, and novelty products. It sells its brands across various distribution channels through direct-to-retail and wholesale licenses, from the mass tier to the luxury market, as well as through various media outlets. The company was formerly known as Candie's, Inc. and changed its name to Iconix Brand Group, Inc. in July 2005. Iconix Brand Group, Inc. was founded in 1978 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COLE NEILSee RemarksOct 31Option Exercise5.701,000,0005,696,0002,871,779Nov 04 06:00 PM
COLE NEILSee RemarksOct 31Sale39.511,000,00039,510,0002,071,779Nov 04 06:00 PM
BLUMBERG DAVIDSee RemarksOct 30Option Exercise20.0230,000600,600147,097Oct 31 04:01 PM
BLUMBERG DAVIDSee RemarksOct 30Sale39.9538,1571,524,495108,940Oct 31 04:01 PM
EMANUEL BARRYDirectorSep 04Option Exercise8.5820,000171,60056,649Sep 08 04:45 PM
1 2 3 4 5 6 next